Introduction {#sec1}
============

In 2015, liver cancer (LC) ranked the third most frequent type of malignancy in males and the sixth most frequent type in females, approximately 343700 and 122300 cases occuring in China, respectively \[[@B1]\]. The total LC-related deaths are the third most frequent type of malignancy \[[@B1],[@B2]\]; however, the etiology of LC remains unclear. Susceptibility factors \[e.g. hepatitis B virus (HBV), age, obesity, type 2 diabetes, consumption of food contaminated with aflatoxin, nonalcoholic fatty liver disease, heavy drinking related cirrhosis, and tobacco use\] may be implicated in the etiology of LC \[[@B3][@B7]\]. Accumulating evidences suggested that besides these mentioned people's lifestyle and environmental factors, some genetic predispositions might also contribute to development of LC.

Folic acid is important for DNA synthesis and methylation, mitosis and controlling related gene expression. Recently, epidemiological investigations showed that sufficient fruits and vegetables intake may be a protective factor for carcinogenesis \[[@B8]\]. It is thought that these potential protective roles of diet attribute to the high level intake of folic acid. Methylenetetrahydrofolate reductase (MTHFR) plays an important role in catalyzing the transition of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (5-MTHF), which is a main plasm form of folate. And 5-MTHF is implicated in a conversion procedure of homocysteine (Hcy) into methionine (Met) and the methylation of DNA. Considering the vital role of MTHFR, variants in *MTHFR* gene may influence the development of cancer.

In humans, MTHFR protein is coded by the *MTHFR* gene which is located on chromosome 1p36.3. *MTHFR* single nucleotide polymorphisms (SNPs) may be a potential biomarker of cancer. In addition, Jiao et al. \[[@B11]\] reported that hepatocellular carcinoma (HCC) patients with HBV-infection carried *MTHFR* rs1801133 AA genotype and A allele may have a better prognosis than those who carried *MTHFR* rs1801133 GG genotype and G allele. Recently, some studies investigated a potential association of *MTHFR* loci with HCC susceptibility \[[@B11][@B15]\]; however, due to the limited sample sizes, the observations might be conflicting. Therefore, in the present study, we included 1507 subjects to perform a case--control study to extensively explore the relationship between *MTHFR* tagging SNPs and the risk of HCC.

Materials and methods {#sec2}
=====================

Study population {#sec2-1}
----------------

Our study recruited 584 consecutive HCC cases from two Clinical Medical College of Fujian Medical University (Fuzhou City, China) during 2002--2016. Two doctors confirmed HCC diagnosis by pathology. The criterion of Barcelona Clinic Liver Cancer (BCLC) was used to determine the stage of HCC \[[@B16],[@B17]\]. In addition, 923 Chinese people without any cancer history were included as controls. We matched HCC patients and controls by region (Eastern China), age and sex. Every subject was notified purpose of the study. All participants provided written informed consent. A questionnaire regarding age, sex, smoking and alcohol status was used to collect the corresponding information. The protocol of this investigation was approved by Ethics Committee of Fujian Medical University. In the present study, the principles of Declaration of Helsinki was conformed. Chronic HBV infection were determined by using hepatitis B surface antigen enzyme-linked immunosorbent assay Kit (InTec, Xiamen, China).

SNPs selection and genotyping {#sec2-2}
-----------------------------

*MTHFR* tagging SNPs were selected through Haploview software, which are described in our previous case--control studies \[[@B18],[@B19]\].

EDTA-anticoagulated blood was donated and collected. According to the standard experimental protocol, genomic DNA was obtained by using a DNA Kit (Promega, Madison, U.S.A.). A SNPscan Kit (Genesky Biotechnologies Inc., Shanghai, China) was used to determine the variants of *MTHFR* SNPs as described in our case--control studies \[[@B20]\]. At this stage, 60 DNA samples were selected and re-analyzed for quality control. Finally, the genotype frequencies were not changed.

Statistical analysis {#sec2-3}
--------------------

In the present study, *χ^2^* test or Fisher's exact test was harnessed to analyze the differences in sex, chronic HBV infection, age, smoking, drinking and the genotype frequencies of HCC patients compared with controls. In addition, age was expressed as means ± standard deviation (SD). The difference in age between two groups was determined by Student's *t* test. With an internet Hardy--Weinberg equilibrium (HWE) test (<http://ihg.gsf.de/cgi-bin/hw/hwa1.pl>), genotype frequencies among controls was used to assess the HWE status \[[@B21],[@B22],[@B23],[@B24]\]. The correlation between *MTHFR* SNPs and HCC risk was evaluated by odds ratios (ORs) and 95% confidence intervals (CIs). Logistic regression analysis was used to determine the associations between *MTHFR* polymorphisms and the risk of HCC by adjusting sex, chronic HBV infection, age, smoking and drinking. A two-tailed *P*\<0.05 was considered as significant. We used SHESIS online program (<http://analysis.bio-x.cn/myAnalysis.php>) to construct *MTHFR* haplotypes \[[@B25]\]. SAS 9.4 version statistical software (SAS Institute, Cary, NC) was used to analyze data. The power of the present study was determined by a power calculating software (<http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize>) (α = 0.05) \[[@B26]\].

Results {#sec3}
=======

Characteristics {#sec3-1}
---------------

As described in [Table 1](#T1){ref-type="table"}, 1507 participants (584 patients and 923 controls) were included in the present study. Male:female ratio of the HCC patients was ∼9:1 (89.90% and 10.10%), controls were recruited in the similar proportion (90.47% males and 9.53% females) to match the distribution of sex and average age (HCC cases = 53.17, SD ± 11.76 years; controls = 53.72, SD ± 9.97 years; *P*=0.327). There were 210 (35.96%) smokers among HCC group and 327 (35.43%) among non-cancer controls, while non-smokers were 374 (64.04%) in HCC cases and 596 (64.57%) in the controls. Drinking and chronic HBV infection ratio in HCC patients was higher than that of controls (29.11 vs. 16.03% and 70.55 vs. 9.21%, respectively). The BCLC stage of HCC was summarized in [Table 1](#T1){ref-type="table"}. The data of SNPs in *MTHFR* gene were listed in [Table 2](#T2){ref-type="table"}.

###### Distribution of selected demographic variables and risk factors in HCC cases and controls

  Variable                Cases (*n*=584)   Controls (*n*=923)   *P*[^1^](#T1TFN1){ref-type="table-fn"}
  ----------------------- ----------------- -------------------- ----------------------------------------
  Age (years)             53.17 (±11.76)    53.72 (±9.97)        0.327
  Age (years)                                                    0.358
  \<53                    264 (45.21)       395 (42.80)          
  ≥53                     320 (54.79)       528 (57.20)          
  Sex                                                            0.717
  Male                    525 (89.90)       835 (90.47)          
  Female                  59 (10.10)        88 (9.53)            
  Smoking status                                                 0.834
  Never                   374 (64.04)       596 (64.57)          
  Ever                    210 (35.96)       327 (35.43)          
  Alcohol use                                                    \<0.001
  Never                   414 (70.89)       775 (83.97)          
  Ever                    170 (29.11)       148 (16.03)          
  Chronic HBV infection                                          \<0.001
  Yes                     412 (70.55)       85 (9.21)            
  No                      172 (29.45)       838 (90.79)          
  BCLC classification                                            
  A                       392 (67.12)                            
  B                       175 (29.97)                            
  C                       17 (2.91)                              

Bold values are statistically significant (*P*\<0.05).

Two-sided *χ*^2^ test and Student's *t* test.

###### Primary information for *MTHFR* polymorphisms

  Genotyped SNPs                                                                           rs3753584 T\>C   rs4846048 A\>G   rs4845882 G\>A   rs1801133 G\>A   rs9651118 T\>C
  ---------------------------------------------------------------------------------------- ---------------- ---------------- ---------------- ---------------- ----------------
  Chromosome                                                                               1                1                1                1                1
  Location (NCBI Build 37)                                                                 11864586         11846252         11843167         11856378         11862214
  Function                                                                                 NearGene-5       Intron           Intron           Missense         Intron
  Regulome DB scores (<http://www.regulomedb.org/>)                                        4                3a               1f               4                5
  Transcription factor binding site (<http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm>)   Y                \-               \-               \-               Y
  MiRNA (miRanda)                                                                          \-               Y                \-               \-               \-
  MAF[^1^](#T2TFN1){ref-type="table-fn"} for Chinese in database                           0.093            0.105            0.198            0.439            0.382
  MAF in our controls (*n*=923)                                                            0.111            0.095            0.216            0.354            0.378
  *P*-value for HWE[^2^](#T2TFN2){ref-type="table-fn"} test in our controls                0.814            0.029            0.437            0.074            0.021
  Genotyping method                                                                        SNPscan          SNPscan          SNPscan          SNPscan          SNPscan
  \% Genotyping value                                                                      99.27%           99.27%           99.27%           99.27%           99.27%

MAF, minor allele frequency.

HWE.

Relationship of MTHFR polymorphisms with HCC patients {#sec3-2}
-----------------------------------------------------

[Table 3](#T3){ref-type="table"} summarizes the *MTHFR* genotype frequencies in HCC patients and control groups. Overall, we found that *MTHFR* rs4846048 and rs4845882 genotype distribution were not statistically significant between two groups.

###### Logistic regression analyses of associations between *MTHFR* rs3753584 T\>C, rs4845882 G\>A, rs1801133 G\>A, rs4846048 A\>G and rs9651118 T\>C polymorphisms and the risk of HCC

  ------------------------ ----------------- -------------------- ------------------- ------- --------------------------------------------------------- ------------- ----------------------- -----------
  Genotype                 Cases (*n*=584)   Controls (*n*=923)   Crude OR (95% CI)   *P*     Adjusted OR[^1^](#T3TFN1){ref-type="table-fn"} (95% CI)   *P*                                   
                           *n*               \%                   *n*                 \%                                                                                                      
  *MTHFR* rs1801133 G\>A                                                                                                                                                                      
  GG                       299               52.00                372                 40.39   1.00                                                                    1.00                    
  GA                       227               39.48                446                 48.43   **0.63 (0.51--0.79)**                                     **\<0.001**   **0.72 (0.54--0.97)**   **0.031**
  AA                       49                8.52                 103                 11.18   **0.59 (0.41--0.86)**                                     **0.006**     0.89 (0.56--1.42)       0.625
  GA + AA                  276               48.00                549                 59.48   **0.63 (0.51--0.77)**                                     **\<0.001**   **0.76 (0.57--0.99)**   **0.045**
  GG+ GA                   526               91.48                818                 88.82   1.00                                                                    1.00                    
  AA                       49                8.52                 103                 11.18   0.74 (0.52--1.06)                                         0.098         1.05 (0.67--1.64)       0.842
  A allele                 325               28.26                652                 35.40                                                                                                   
  *MTHFR* rs3753584 T\>C                                                                                                                                                                      
  TT                       431               74.96                729                 79.15   1.00                                                                    1.00                    
  CT                       139               24.17                180                 19.54   **1.31 (1.02--1.68)**                                     **0.037**     **1.67 (1.20--2.32)**   **0.003**
  CC                       5                 0.87                 12                  1.30    0.71 (0.25--2.01)                                         0.514         0.64 (0.16--2.57)       0.530
  CT+CC                    144               25.04                192                 20.85   1.27 (0.99--1.62)                                         0.059         **1.59 (1.15--2.20)**   **0.005**
  TT+CT                    570               99.13                909                 98.70   1.00                                                                    1.00                    
  CC                       5                 0.87                 12                  1.30    0.67 (0.23--1.90)                                         0.445         0.58 (0.15--2.29)       0.434
  C allele                 149               12.96                204                 11.07                                                                                                   
  *MTHFR* rs4845882 G\>A                                                                                                                                                                      
  GG                       329               57.22                562                 61.02   1.00                                                                    1.00                    
  GA                       222               38.61                320                 34.74   1.19 (0.95--1.48)                                         0.128         1.26 (0.94--1.67)       0.121
  AA                       24                4.17                 39                  4.23    1.05 (0.62--1.78)                                         0.853         1.18 (0.59--2.36)       0.650
  GA+AA                    246               42.78                359                 38.98   1.17 (0.95--1.45)                                         0.145         1.25 (0.94--1.65)       0.120
  GG+GA                    551               95.83                882                 95.77   1.00                                                                    1.00                    
  AA                       24                4.17                 39                  4.23    0.99 (0.59--1.66)                                         0.955         1.08 (0.54--2.15)       0.831
  A allele                 270               23.48                398                 21.61                                                                                                   
  *MTHFR* rs4846048 A\>G                                                                                                                                                                      
  AA                       465               80.87                760                 82.52   1.00                                                                    1.00                    
  AG                       107               18.61                147                 15.96   1.19 (0.90--1.57)                                         0.215         1.17 (0.82--1.68)       0.395
  GG                       3                 0.52                 14                  1.52    0.35 (0.10--1.23)                                         0.101         0.26 (0.06--1.23)       0.090
  AG+GG                    110               19.13                161                 17.48   1.12 (0.85--1.46)                                         0.421         1.08 (0.76--1.54)       0.668
  AA+AG                    572               99.48                907                 98.49   1.00                                                                    1.00                    
  GG                       3                 0.52                 14                  1.52    0.34 (0.10--1.19)                                         0.091         0.25 (0.05--1.20)       0.083
  G allele                 113               9.82                 175                 9.50                                                                                                    
  *MTHFR* rs9651118 T\>C                                                                                                                                                                      
  TT                       216               37.57                340                 36.92   1.00                                                                    1.00                    
  TC                       267               46.43                466                 50.60   0.90 (0.72--1.13)                                         0.373         **0.67 (0.49--0.90)**   **0.008**
  CC                       92                16.00                115                 12.49   1.26 (0.91--1.74)                                         0.162         0.85 (0.55--1.31)       0.458
  TC+CC                    359               62.43                581                 63.08   0.97 (0.78--1.21)                                         0.800         **0.70 (0.53--0.93)**   **0.015**
  TT+TC                    483               84.00                806                 87.51   1.00                                                                    1.00                    
  CC                       92                16.00                115                 12.49   1.34 (0.99--1.80)                                         0.056         1.07 (0.72--1.59)       0.758
  C allele                 451               39.22                696                 37.79                                                                                                   
  ------------------------ ----------------- -------------------- ------------------- ------- --------------------------------------------------------- ------------- ----------------------- -----------

Adjusted for age, sex, smoking, status of chronic HBV infection and drinking.

Bold values are statistically significant (*P*\<0.05).

Compared with rs1801133 GG genotype frequency, we found that *MTHFR* rs1801133 GA genotype significantly decreased the risk of HCC (*P*\<0.001). When rs1801133 GG frequency was used as reference, there was a difference in *MTHFR* rs1801133 AA and AA/GA genotype frequency between two groups (*P*=0.006 and *P*\<0.001, respectively). Adjustment for sex, chronic HBV infection, age, smoking and drinking, the significant decreased risk also re-appeared in two genetic models (GA vs. GG: adjusted *P*=0.031, AA/GA vs. GG: adjusted *P*=0.045, respectively).

We also found *MTHFR* rs3753584 had an increased susceptibility to HCC (CT vs. TT: *P*=0.037). Adjustments for sex, chronic HBV infection, age, smoking and drinking, the findings were more significant (CT vs. TT: adjusted *P*=0.003 and TC/CC vs. TT: adjusted *P*=0.005).

In crude comparison, we did not find any relationship between *MTHFR* rs9651118 and HCC susceptibility. However, when adjusted for sex, chronic HBV infection, age, smoking and drinking, a statistically decreased risk of HCC was identified in two genetic model (CT vs. TT: adjusted *P*=0.008 and TC/CC vs. TT: adjusted *P*=0.015).

Association of MTHFR polymorphisms with HCC in a stratification analysis {#sec3-3}
------------------------------------------------------------------------

[Table 4](#T4){ref-type="table"} showed the *MTHFR* genotype frequencies in the subgroup analyses by the status of chronic HBV infection. We found that *MTHFR* rs1801133 and rs9651118 polymorphisms were associated with the decreased risk of HCC in no chronic HBV infection subgroup (rs1801133: GA vs. GG: adjusted *P*=0.001 and GA/AA vs. GG: adjusted *P*=0.001; and rs9651118: CT vs. TT: adjusted *P*=0.021 and TC/CC vs. TT: adjusted *P*=0.037). However, we identified that *MTHFR* rs1801133 polymorphism was associated with HCC risk in chronic HBV infection subgroup (rs1801133: AA vs. GG: adjusted *P*=0.035 and GA/AA vs. GG: adjusted *P*=0.035). Additionally, the association of *MTHFR* rs3753584 and rs4845882 polymorphism with the risk of HCC was also found (rs3753584: CT vs. TT: adjusted *P*=0.003 and TC/CC vs. TT: adjusted *P*=0.005; rs4845882: GA vs. GG: adjusted *P*=0.022 and GA/AA vs. GG: adjusted *P*=0.021).

###### Stratified analyses between *MTHFR* polymorphisms and HCC risk by status of chronic HBV infection

  Genotype                 Chronic HBV infection (Yes)   Adjusted OR[^1^](#T4TFN1){ref-type="table-fn"}   *P*[^1^](#T4TFN1){ref-type="table-fn"}   Chronic HBV infection (No)   Adjusted OR[^1^](#T4TFN1){ref-type="table-fn"}   *P*[^1^](#T4TFN1){ref-type="table-fn"}                                                        
  ------------------------ ----------------------------- ------------------------------------------------ ---------------------------------------- ---------------------------- ------------------------------------------------ ---------------------------------------- ----- -------- ----- ------- ----------------------- -----------
  *MTHFR* rs1801133 G\>A                                                                                                                                                                                                                                                                                                       
  GG                       210                           51.98                                            51                                       60.00                        1.00                                                                                      89    52.05    321   38.40   1.00                    
  GA                       163                           40.35                                            32                                       37.65                        1.53 (0.91--2.79)                                0.111                                    64    37.43    414   49.52   **0.53 (0.37--0.76)**   **0.001**
  AA                       31                            7.67                                             2                                        2.35                         **5.06 (1.12--22.88)**                           **0.035**                                18    10.53    101   12.08   0.63 (0.36--1.10)       0.104
  GA + AA                  194                           48.02                                            34                                       40.00                        **1.73 (1.04--2.87)**                            **0.035**                                82    47.95    515   61.60   **0.55 (0.39--0.77)**   **0.001**
  GG+ GA                   373                           92.33                                            83                                       97.65                        1.00                                                                                      153   89.47    735   87.92   1.00                    
  AA                       31                            7.67                                             2                                        2.35                         4.20 (0.95--18.67)                               0.059                                    18    10.53    101   12.08   0.86 (0.50--1.47)       0.581
  A allele                 225                           27.85                                            36                                       21.18                                                                                                                  100   29.24    616   36.84                           
  *MTHFR* rs3753584 T\>C                                                                                                                                                                                                                                                                                                       
  TT                       312                           77.23                                            69                                       81.18                        1.00                                                                                      119   69.59    660   78.95   1.00                    
  CT                       88                            21.78                                            15                                       17.65                        1.19 (0.62--2.26)                                0.600                                    51    29.82    165   19.74   **1.78 (1.22--2.60)**   **0.003**
  CC                       4                             0.99                                             1                                        1.18                         0.69 (0.07--6.69)                                0.748                                    1     0.58     11    1.32    0.50 (0.06--3.95)       0.512
  CT+CC                    92                            22.77                                            16                                       18.82                        1.15 (0.62--2.16)                                0.655                                    52    30.41    176   21.05   **1.70 (1.17--2.46)**   **0.005**
  TT+CT                    400                           99.01                                            84                                       98.82                        1.00                                                                                      170   99.42    825   98.68   1.00                    
  CC                       4                             0.99                                             1                                        1.18                         0.67 (0.07--6.43)                                0.725                                    1     0.58     11    1.32    0.44 (0.06--3.42)       0.428
  C allele                 96                            11.88                                            17                                       10.00                                                                                                                  53    15.50    187   11.18                           
  *MTHFR* rs4845882 G\>A                                                                                                                                                                                                                                                                                                       
  GG                       240                           59.41                                            48                                       56.47                        1.00                                                                                      89    52.05    514   61.48   1.00                    
  GA                       148                           36.63                                            33                                       38.82                        0.82 (0.49--1.37)                                0.448                                    74    43.27    287   34.33   **1.50 (1.06--2.11)**   **0.022**
  AA                       16                            3.96                                             4                                        4.71                         0.71 (0.21--2.43)                                0.586                                    8     4.68     35    4.19    1.40 (0.62--3.15)       0.415
  GA+AA                    164                           40.59                                            37                                       43.53                        0.81 (0.49--1.33)                                0.402                                    82    47.95    322   38.52   **1.49 (1.06--2.08)**   **0.021**
  GG+GA                    388                           96.04                                            81                                       95.29                        1.00                                                                                      163   95.32    801   95.81   1.00                    
  AA                       16                            3.96                                             4                                        4.71                         0.77 (0.23--2.58)                                0.670                                    8     4.68     35    4.19    1.19 (0.54--2.64)       0.668
  A allele                 180                           22.28                                            41                                       24.12                                                                                                                  90    26.32    357   21.35                           
  *MTHFR* rs4846048 A\>G                                                                                                                                                                                                                                                                                                       
  AA                       330                           81.68                                            66                                       77.65                        1.00                                                                                      135   78.95    694   83.01   1.00                    
  AG                       71                            17.57                                            18                                       21.18                        0.76 (0.41--1.42)                                0.391                                    36    21.05    129   15.43   1.45 (0.95--2.20)       0.082
  GG                       3                             0.74                                             1                                        1.18                         0.65 (0.05--7.75)                                0.729                                    0     0.00     13    1.55    \-                      \-
  AG+GG                    74                            18.32                                            19                                       22.35                        0.76 (0.41--1.39)                                0.368                                    36    21.05    142   16.99   1.31 (0.87--1.99)       0.197
  AA+AG                    401                           99.26                                            84                                       98.82                        1.00                                                                                      171   100.00   823   98.45   1.00                    
  GG                       3                             0.74                                             1                                        1.18                         0.68 (0.06--8.14)                                0.761                                    0     0.00     13    1.55    \-                      \-
  G allele                 77                            9.53                                             20                                       11.76                                                                                                                  36    10.53    155   9.27                            
  *MTHFR* rs9651118 T\>C                                                                                                                                                                                                                                                                                                       
  TT                       135                           33.42                                            22                                       25.88                        1.00                                                                                      81    47.37    318   38.04   1.00                    
  TC                       199                           49.26                                            48                                       56.47                        0.59 (0.33--1.06)                                0.078                                    68    39.77    418   50.00   **0.66 (0.46--0.94)**   **0.021**
  CC                       70                            17.33                                            15                                       17.65                        0.72 (0.34--1.54)                                0.394                                    22    12.87    100   11.96   0.88 (0.52--1.50)       0.638
  TC+CC                    269                           66.58                                            63                                       74.12                        0.62 (0.36--1.09)                                0.095                                    90    52.63    518   61.96   **0.70 (0.50--0.98)**   **0.037**
  TT+TC                    334                           82.67                                            70                                       82.35                        1.00                                                                                      149   87.13    736   88.04   1.00                    
  CC                       70                            17.33                                            15                                       17.65                        1.00 (0.52--1.92)                                0.995                                    22    12.87    100   11.96   1.09 (0.66--1.80)       0.727
  C allele                 339                           41.96                                            78                                       45.88                                                                                                                  112   32.75    618   36.96                           

Adjusted for age, sex, smoking, status of chronic HBV infection and drinking.

Bold values are statistically significant (*P*\<0.05).

MTHFR haplotypes {#sec3-4}
----------------

We constructed six haplotypes of *MTHFR* gene ([Table 5](#T5){ref-type="table"}). Haplotype analysis of this gene suggested that *MTHFR* A~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~ haplotype was a protective factor for HCC (*P***=**0.008). However, *MTHFR* G~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~ was associated the risk of HCC (*P***=**0.003).

###### *MTHFR* haplotype frequencies (%) and risk of HCC

  Haplotypes                                                     HCC Cases (*n*=1151)   Controls (*n*=1841)   Crude OR (95% CI)   *P*                             
  -------------------------------------------------------------- ---------------------- --------------------- ------------------- ------- ----------------------- -----------
  G~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~C~rs9651118~   438                    38.05                 685                 37.21   1.00                    
  A~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~   317                    27.54                 633                 34.38   **0.78 (0.65--0.94)**   **0.008**
  G~rs1801133~C~rs3753584~A~rs4845882~A~rs4846048~T~rs9651118~   140                    12.63                 194                 10.54   1.13 (0.88**--**1.45)   0.339
  G~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~   111                    9.64                  112                 6.08    **1.55 (1.16--2.07)**   **0.003**
  G~rs1801133~T~rs3753584~A~rs4845882~G~rs4846048~T~rs9651118~   109                    9.47                  170                 9.23    1.00 (0.77**--**1.31)   0.984
  G~rs1801133~T~rs3753584~A~rs4845882~A~rs4846048~T~rs9651118~   13                     1.13                  22                  1.20    0.92 (0.46**--**1.85)   0.824
  Others                                                         23                     2.00                  25                  1.36    1.44 (0.81**--**2.57)   0.216

Bold values are statistically significant (*P*\<0.05).

The power of the present study (α = 0.05) {#sec3-5}
-----------------------------------------

The present study's power was determined (α = 0.05). For *MTHFR* rs1801133 polymorphism, the power value was 0.835 in the GA vs. GG genetic model and 0.726 in GA/AA vs. GG genetic model. For *MTHFR* rs3753584 locus, the power of the present study was 0.984 in the CT vs. TT genetic model and 0.965 in CT/CC vs. TT genetic model. When we focused on the *MTHFR* rs965118 polymorphism, the power value was 0.935 in the CT vs. TT genetic model and 0.910 in CT/CC vs. TT genetic model. In addition, the power of *MTHFR* A~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~ and *MTHFR* G~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~ haplotypes were 0.771 and 0.844, respectively.

In the subgroup without chronic HBV infection, we found that the power value was 0.946 in GA vs. GG genetic model and 0.944 in GA/AA vs. GG genetic model for *MTHFR* rs1801133 polymorphism and 0.852 in the CT vs. TT genetic model and 0.803 in CT/CC vs. TT genetic model for *MTHFR* rs3753584 locus. The power value of other subgroups was less than 0.8 (data were not shown).

Discussion {#sec4}
==========

The HCC susceptibility to individuals may be affected by certain environmental risk factors \[[@B27],[@B28]\]. The high HCC morbidity in certain regions of sub-Saharan Africa and Asia largely attributes to the prevalence of chronic HBV infection. However, individual's hereditary factor also could influence the risk of HCC \[[@B28],[@B29]\]. MTHFR and 5-MTHF may be implicated in DNA methylation, synthesis and repair. Thus, variants in *MTHFR* could influence the risk of cancer. Several case--control studies were designed to identify the association of *MTHFR* variants with HCC risk. However, the included participants in these studies were relatively small. In addition, the observations of pooled analyses were conflicting \[[@B30]\]. Here, we conducted a study with related large sample sizes to assess a potential correlation between *MTHFR* SNPs and susceptibility of HCC. Our results suggested the associations of *MTHFR* rs3753584, rs9651118 and rs1801133 polymorphisms with HCC development. In addition, haplotype analysis of *MTHFR* gene suggested that *MTHFR* G~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~ increased the susceptibility of HCC. The power value of the present study also conferred these associations (power value \> 0.80).

Rs1801133 polymorphism is the most extensively studied SNP in *MTHFR* gene. This SNP is a missense variant (Ala→Val at 226 position). MTHFR is vital enzyme in the process of remethylation, and catalyzes Hcy to Met. Rs1801133 locus codes the NH~2~-terminal catalytic domain of MTHFR. MTHFR rs1801133 A allele decreases the activity of protein enzyme \[[@B34]\]. A few case--control studies identified that rs1801133 increased the susceptibility of HCC \[[@B15],[@B35],[@B36]\]. Another study identified that this SNP did not confer risk to HCC \[[@B37]\]. However, Jiao et al. \[[@B11]\] reported that AA genotype and A allele of *MTHFR* rs1801133 may confer a protective effect on HCC in HBV-infected individuals. Some pooled analysis investigated a potential correlation of *MTHFR* rs1801133 with HCC risk. Several meta-analyses reported that *MTHFR* rs1801133 A allele might increase the risk of HCC \[[@B31][@B33],[@B38]\]. However, in another meta-analysis, Qin et al. \[[@B30]\] suggested that there was no significant association between *MTHFR* rs1801133 locus and HCC risk. The observations were controversial. Thus, we conducted a related large sample size study to investigate the correlation of rs1801133 locus with HCC risk. We concluded that rs1801133 A allele was a protective factor for HCC. Recently, some pooled-analyses demonstrated that this locus is protective for the development of colorectal cancer in Asians \[[@B39],[@B40]\]. An Ala→Val substitute at 226 position in MTHFR may increase the 5,10-methylenetetrahydrofolate for DNA synthesis \[[@B41],[@B42]\], which may be protective for cancer development. In the future, more studies should be conducted to identify whether G→A variant in *MTHFR* rs1801133 locus is a protective factor for HCC development.

To our knowledge, we first clarified the impact of *MTHFR* rs3753584 T\>C polymorphism with hepatocarcinogenesis. *MTHFR* rs3753584 is located in nearGene-5, which may regulate the stability, transcription and translation of RNA. Liu et al. \[[@B43]\] suggested that *MTHFR* rs3753584 locus affected the development of lung cancer. Another study found that *MTHFR* rs3753584 variants increased the susceptibility of colon cancer \[[@B44]\]. Here, we identified that *MTHFR* rs3753584 may confer a risk to HCC. Our observation was similar to those findings mentioned above.

Lu et al. \[[@B45]\] conducted a study to detect the correlation of *MTHFR* rs9651118 with susceptibility to breast cancer (BC), and the results suggested that rs9651118 CC genotype decreased the risk of BC. Additionally, in Caucasians, Swartz et al. \[[@B46]\] reported that this variant might be a factor that decreased the susceptibility of lung cancer. In Asians, Ding et al. \[[@B47]\] reported that *MTHFR* rs9651118 T\>C polymorphism has a tendency to decrease risk of esophagogastric junction adenocarcinoma. In the present study, we first explored the association between *MTHFR* rs9651118 T\>C polymorphism and risk of HCC. Our findings clarified that *MTHFR* rs9651118 C allele was relevant to a protective role for hepatocarcinogenesis. *MTHFR* rs9651118 was an intron SNP, which may influence the alternative splicing pattern. A functional study indicated that rs9651118 CC genotype of *MTHFR*, compared with TT genotype, reduced the Hcy level \[[@B48]\]. Recently, a dose--response meta-analysis concluded that each 5 μmol/l Hcy level promoting increased the incidence of digestive tract cancer by 7% \[[@B49]\]. Thus, *MTHFR* rs9651118 C allele may reduce the Hcy level, and then decrease the susceptibility of HCC.

Our findings suggested *MTHFR* G~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~ increased the susceptibility of HCC. We first investigated the potential correlation of these *MTHFR* tagging SNPs haplotypes with HCC susceptibility. It could be used as a potential biomarker for HCC diagnosis. Previous investigations have focused on the relationship between *MTHFR* haplotypes of these tagging SNPs and cancer susceptibility; however, *MTHFR* G~rs1801133~T~rs3753584~G~rs4845882~A~rs4846048~T~rs9651118~ was not found to be associated with the risk of non-small cell lung cancer \[[@B50]\] and esophagogastric junction adenocarcinoma \[[@B47]\]. In the future, these findings should be further validated.

This hospital-based study might have some potential limitations. First, though we recruited 1507 subjects to investigate a relationship of *MTHFR* tagging SNPs and the risk of HCC here, the sample size might be insufficient to identify weak associations of HCC. Second, in the present study, we only included several risk factors (e.g. sex, chronic HBV infection, age, smoking and drinking), other environmental factors were not considered. Third, the present study was hospital-based, which could not fully represent the Chinese population and the bias might have happened. In the future, population-based investigations are needed to further explore the role of *MTHFR* SNPs to risk of HCC. Fourth, the intake of folate and diet habits were not collected in our study. Thus, we did not focus on the association of *MTHFR* variants and folate level with the susceptibility of HCC. Finally, we only evaluated the *MTHFR* SNPs with HCC, polymorphisms in other one-carbon metabolism genes were not included.

Taken together, in Chinese Han population, *MTHFR* rs9651118 and rs1801133 polymorphisms may be protective for HCC. However, *MTHFR* rs3753584 polymorphism is a candidate for susceptibility to HCC. In the future, these findings should be further validated in additional studies.
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